Fabio Barassi

1.8k citations

12 papers · 1.5k indexed · 1 hit paper · h-index 12

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Molecular Biology 7
- RNA modifications and cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
Oncology 7
- Cancer-related Molecular Pathways 3
- Lung Cancer Research Studies 2

Co-authors: Fiamma Buttitta (12 shared papers)Lara Felicioni (10 shared papers)Simona Salvatore (8 shared papers)Antonio Marchetti (6 shared papers)Antonio Chella (6 shared papers)Felice Mucilli (6 shared papers)Andrea Mezzetti (4 shared papers)Rocco Sacco (5 shared papers)
Journals: The Journal of Pathology (3 papers)Clinical Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)Human Mutation (1 paper)International Journal of Cancer (1 paper)
Partner nations: Italy United States India

In The Last Decade

Fabio Barassi

12 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment 2005 · 670 citations

Peers

Countries citing papers authored by Fabio Barassi

Since Specialization

Citations

This map shows the geographic impact of Fabio Barassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Barassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Barassi more than expected).

Fields of papers citing papers by Fabio Barassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Barassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Barassi. The network helps show where Fabio Barassi may publish in the future.

Co-authors

The 25 scholars most cited alongside Fabio Barassi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fabio Barassi Line = papers co-authored together Fabio Barassi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment Journal of Clinical Oncology ·Antonio Marchetti, Carla Martella, Lara Felicioni, Fabio Barassi, Simona Salvatore, Antonio Chella, Pierpaolo Camplese, T Iarussi, Felice Mucilli, Andrea Mezzetti, Franco Cuccurullo, Rocco Sacco, Fiamma Buttitta Hit paper breakdown →	2005	670
2	Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas Clinical Cancer Research ·Mattia Barbareschi, Fiamma Buttitta, Lara Felicioni, Sabrina Cotrupi, Fabio Barassi, Maela Del Grammastro, Antonella Ferro, Paolo Palma, Enzo Galligioni, Antonio Marchetti	2007	156
3	Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features International Journal of Cancer ·Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu, Lara Felicioni, Antonio Chella, Diego Paolizzi, Giuseppe Lattanzio, Simona Salvatore, Pierpaolo Camplese, Sandra Rosini, T Iarussi, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Antonio Marchetti	2006	147
4	Survivin gene expression in early‐stage non‐small cell lung cancer The Journal of Pathology ·Monica Falleni, Caterina Pellegrini, Antonio Marchetti, Barbara Oprandi, Fiamma Buttitta, Fabio Barassi, L. Santambrogio, Guido Coggi, Silvano Bòsari	2003	136
5	PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma The Journal of Pathology ·Fiamma Buttitta, Lara Felicioni, Fabio Barassi, Carla Martella, Diego Paolizzi, Giuseppina Fresu, Simona Salvatore, Franco Cuccurullo, Andrea Mezzetti, Daniela Campani, Antonio Marchetti	2005	86
6	Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung Human Mutation ·Antonio Marchetti, Lara Felicioni, Giuseppe Pelosi, Maela Del Grammastro, Caterina Fumagalli, Mariagrazia Sciarrotta, Sara Malatesta, Antonio Chella, Fabio Barassi, Felice Mucilli, Pierpaolo Camplese, Tommaso D’Antuono, Rocco Sacco, Fiamma Buttitta	2008	59
7	Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization Cancer Research ·Simona Giglio, Francesca Mancini, Francesca Gentiletti, Giorgia Sparaco, Lara Felicioni, Fabio Barassi, Carla Martella, Andrea Prodosmo, Stefano Iacovelli, Fiamma Buttitta, Antonella Farsetti, Silvia Soddu, Antonio Marchetti, Ada Sacchi, Alfredo Pontecorvi, Fabiola Moretti	2005	47
8	Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients Clinical Cancer Research ·Fiamma Buttitta, Carla Martella, Fabio Barassi, Lara Felicioni, Simona Salvatore, Sandra Rosini, Tommaso D’Antuono, Antonio Chella, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Franco Cuccurullo, Robert Callahan, Antonio Marchetti	2005	42
9	Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation Laboratory Investigation ·Antonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, Monica Falleni, Solange Romagnoli, Lara Felicioni, Fabio Barassi, Simona Salvatore, Antonio Chella, Carlo Alberto Angeletti, Massimo Roncalli, Guido Coggi, Silvano Bòsari	2002	41
10	mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients The Journal of Pathology ·Antonio Marchetti, Fiamma Buttitta, Gloria Bertacca, Katia Zavaglia, Generoso Bevilacqua, Domenico Angelucci, Paolo Viacava, Antonio Giuseppe Naccarato, Angelo Giovanni Bonadio, Fabio Barassi, Lara Felicioni, Simona Salvatore, Felice Mucilli	2001	35
11	Down Regulation of High in Normal-1 ( *HIN-1* ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome Clinical Cancer Research ·Antonio Marchetti, Fabio Barassi, Carla Martella, Antonio Chella, Simona Salvatore, A Castrataro, Felice Mucilli, Rocco Sacco, Fiamma Buttitta	2004	26
12	Human Telomerase Reverse Transcriptase mRNA Expression Assessed by Real-Time Reverse Transcription Polymerase Chain Reaction Predicts Chemosensitivity in Patients With Ovarian Carcinoma Journal of Clinical Oncology ·Fiamma Buttitta, Caterina Pellegrini, Antonio Marchetti, Angiolo Gadducci, Stefania Cosio, Lara Felicioni, Fabio Barassi, Simona Salvatore, Carla Martella, Guido Coggi, Silvano Bòsari	2003	23

About Fabio Barassi

Fabio Barassi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), RNA modifications and cancer (2 papers), BRCA gene mutations in cancer (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Breast Lesions and Carcinomas (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Oncology (850 citations), Pulmonary and Respiratory Medicine (898 citations), Cancer Research (374 citations), Molecular Biology (710 citations) and Genetics (93 citations). Fabio Barassi has collaborated with scholars based in Italy, United States and India. Frequent co-authors include Fiamma Buttitta, Lara Felicioni, Simona Salvatore, Antonio Marchetti, Antonio Chella, Felice Mucilli, Andrea Mezzetti, Rocco Sacco, Carla Martella and Pierpaolo Camplese. Their work appears in journals such as The Journal of Pathology, Clinical Cancer Research, Journal of Clinical Oncology, Human Mutation and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact